---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-25-037598"
form_type: "8-K"
ticker: "AHCO"
cik: "0001725255"
company_name: "AdaptHealth Corp."
filed_at: "2025-08-05T23:59:59+00:00"
generated_at: "2026-05-17T20:51:18.332024+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# AdaptHealth Q2 2025 revenue $800.4M, net income $14.7M; lowers FY adjusted EBITDA guidance

## Summary
- Net revenue $800.4M, down 0.7% YoY; net income $14.7M vs $19.4M in prior year.
- Adjusted EBITDA $155.5M, down 5.9% YoY; year-to-date cash flow from ops $257.5M.
- FY 2025 revenue guidance narrowed to $3.18B-$3.26B; adjusted EBITDA lowered to $642M-$682M.
- Closed sales of certain incontinence and infusion assets in Wellness at Home segment.
- Announces new capitated partnership with a major national healthcare system (no details).

## SEC filing metadata
- accession: 0001628280-25-037598
- form_type: 8-K
- ticker: AHCO
- cik: 0001725255
- company_name: AdaptHealth Corp.
- filed_at: 2025-08-05T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1725255/000162828025037598/0001628280-25-037598-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1725255/000162828025037598/ahco-20250805.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-25-037598
- JSON: https://secwatch.observer/filing/0001628280-25-037598.json
- Plain text: https://secwatch.observer/filing/0001628280-25-037598.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.